{"id":"https://genegraph.clinicalgenome.org/r/02502f63-5ad3-4e2c-acd0-1c837752545dv1.0","type":"EvidenceStrengthAssertion","dc:description":"The ERCC6 gene is located on chromosome 10 at 10q11.23 and encodes the Excision Repair 6, Chromatin Remodeling Factor protein, a DNA-binding protein that is important in transcription-coupled excision repair. ERCC6 was first reported in relation to autosomal recessive Cockayne spectrum with or without cerebrooculofacioskeletal syndrome in 1992 (Troelstra et al., PMID:1339317). Cockayne spectrum with or without cerebrooculofacioskeletal syndrome is characterized by growth failure at birth, with little or no postnatal neurologic development in addition to congenital cataracts or other structural anomalies of the eye, early postnatal contractures of the spine (kyphosis, scoliosis) and joints, and death usually occurring by age five years. This term lumps Cockayne syndrome type 2/B (CSB), cerebrooculofacioskeletal syndrome 1 (COFS syndrome), and De Sanctis-Cacchione syndrome into a spectrum of disease. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in inheritance pattern and/or phenotypic variability. Therefore, the following disease entities have been split into multiple disease entities, Cockayne spectrum with or without cerebrooculofacioskeletal syndrome (OMIM: 133540, 214150, 278800), premature ovarian failure 11 (OMIM: 616946), UV-sensitive syndrome 1 (OMIM: 600630), and susceptibilities to [lung] cancer (OMIM: 211980) and age-related macular degeneration (OMIM: 613761). 10 variants (nonsense, frameshift, canonical splice site, and inframe indel) that have been reported in 5 probands in 4 publications (Mallery et al., 1998, PMID:9443879; Colella et al., 1999, PMID:10196384; Laugel et al., 2010, PMID:19894250; Zhang et al., 2020, PMID:31558084) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be LOF. This gene-disease relationship is also supported by experimental evidence (animal models, functional and phenotypic rescue, in vitro functional assays, and biochemical function) (Van der Horst et al., 1997, PMID: 9150142; Bradsher et al., 2002, PMID:12419226; Ciaffardini et al., 2014, PMID:24874740;  Wang et al., 2014, PMID:25249633). One mouse model recapitulates some characteristic phenotypes of Cockayne syndrome, while both rRNA rates of transcription and UV-sensitivity are rescued in other models. It was also demonstrated that ERCC6 is essential to neuronal differentiation & neuritogenesis, consistent with delayed neurologic development seen in patients. Additionally, transcription-coupled repair of UV damage was shown to be inhibited by variants in ERCC6. In summary, ERCC6 is definitively associated with autosomal recessive Cockayne spectrum with or without cerebrooculofacioskeletal syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders Gene Curation Expert Panel on the meeting date July 15, 2022 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/02502f63-5ad3-4e2c-acd0-1c837752545d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e9dbf99e-d648-465c-8aa5-0840e76c0aeb","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e9dbf99e-d648-465c-8aa5-0840e76c0aeb_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2023-02-18T20:18:53.021Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/e9dbf99e-d648-465c-8aa5-0840e76c0aeb_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2022-08-18T10:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9dbf99e-d648-465c-8aa5-0840e76c0aeb_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9dbf99e-d648-465c-8aa5-0840e76c0aeb_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e5be3ac-46c8-4496-b13b-e19d05d1b7aa","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/532709ed-b1cb-4fca-a4a8-2648494c6424","type":"Finding","dc:description":"Humans diagnosed with Cockayne spectrum with or without cerebrooculofacioskeletal syndrome present with all of the same features seen in this model. The only major difference was that ERCC6-deficient mice showed increased susceptibility to skin cancer whereas human patients do not. The lack of cancer predisposition in human CS patients may be attributable to a global genome repair process in humans that is more effective than it is in rodents.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150142","rdfs:label":"Cockayne syndrome B mice generated with variant from patient","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fbf0e765-66cc-4fec-9f99-f19d0a6037e2","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3408756-c107-43cf-bb99-bab2dedbbc20","type":"Finding","dc:description":"After treatment with DRB, an inhibitor of RNA pol II, the patient cells (CS1AN) exhibit very low rates of rRNA synthesis, consistent with the disease mechanism. Cells expressing the wild-type ERCC6 remain transcriptionally active following treatment with DRB. The low levels of rRNA synthesis seen in ERCC6 deficient patient cells are rescued following transfection with the wild-type ERCC6 gene.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12419226","rdfs:label":"Functional rescue of patient derived cells with wild-type","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2d4905ce-9527-40b6-a5a5-bce77dddb42f","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5405fe2b-be5b-47ca-93d9-cbfd58839184","type":"Finding","dc:description":"Both CS1ANsv derivatives with WT knocked back in rescued the UV sensitivity of the Cockayne syndrome fibroblasts.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25249633","rdfs:label":"UV Sensitivity in CS Fibroblasts Rescued","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/e9dbf99e-d648-465c-8aa5-0840e76c0aeb_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d269e52c-3378-4da0-9f5d-d43c22097b55","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea14f08b-315d-456d-a80d-0c8d48691bdf","type":"FunctionalAlteration","dc:description":"Following varying doses of UV, CS1AN cells showed similar survival rates to the mouse ERCC6 -/- knockout fibroblasts, far below the range of wild-type mouse fibroblasts and even heterozygous knockout +/- ERCC6 mouse fibroblasts. This is indicative of defective transcription-coupled repair due to the inability of cells to repair damage following UV exposure.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150142","rdfs:label":"Survival of CS1AN Following UV-Light Exposure"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e9dbf99e-d648-465c-8aa5-0840e76c0aeb_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e668d74-ea06-4675-a735-b99b76c39e9d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79df8cac-b533-4b5e-87cf-507cc4d14118","type":"Finding","dc:description":"These findings are relevant to disease as they underscore the molecular basis of some of the neurological symptoms reported in patients with Cockayne syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24874740","rdfs:label":"ERCC6 essential to neuronal differentiation & neuritogenesis","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/37ee2af4-e883-44c3-86ff-290ce3326611","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae7bba23-916b-450d-82f7-eeafd716edf2","type":"Finding","dc:description":"Patients with Cockayne spectrum with or without cerebrooculofacioskeletal syndrome have increased cellular sensitivity to UV light.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150142","rdfs:label":"Impaired TCR Consistent with UV sensitivity","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/e9dbf99e-d648-465c-8aa5-0840e76c0aeb_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/caacf9c5-cfd7-4e86-9dd1-47c0d892d12f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/09049289-4179-41be-8e96-32bbec4c194b","type":"EvidenceLine","dc:description":"Leads to a truncated protein of 367 amino acids.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/09049289-4179-41be-8e96-32bbec4c194b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10196384","allele":{"id":"https://genegraph.clinicalgenome.org/r/f6b63710-f4a1-4b42-ae1c-43ea2abed48e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000124.4(ERCC6):c.972dup (p.Glu325fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251923"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/217c4f13-0083-403d-97cb-3757a2483a16","type":"EvidenceLine","dc:description":"Leads to a truncated protein of 681 amino acids.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/217c4f13-0083-403d-97cb-3757a2483a16_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10196384","allele":{"id":"https://genegraph.clinicalgenome.org/r/4178f8be-fcaf-41c1-98e1-beba60f1f6ce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000124.4(ERCC6):c.1971_1974dup (p.Thr659LeufsTer24)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573131703"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/caacf9c5-cfd7-4e86-9dd1-47c0d892d12f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10196384","rdfs:label":"CS2PV","allele":[{"id":"https://genegraph.clinicalgenome.org/r/f6b63710-f4a1-4b42-ae1c-43ea2abed48e"},{"id":"https://genegraph.clinicalgenome.org/r/4178f8be-fcaf-41c1-98e1-beba60f1f6ce"}],"detectionMethod":"Nucleotides 868–1757 and 1197–2107 were amplified by PCR from the CSB cDNA of CS2PV cells and the resulting fragments were cloned into the pMOSBlue T-vector (Amersham); several clones were sequenced directly using the ThermoSequenase cycle sequencing kit (Amersham).","firstTestingMethod":"PCR","phenotypeFreeText":"Calcifications by cranial CT","phenotypes":["obo:HP_0000252","obo:HP_0000519","obo:HP_0001321","obo:HP_0003431","obo:HP_0001518","obo:HP_0000568","obo:HP_0001510","obo:HP_0012447","obo:HP_0005684","obo:HP_0001263"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/217c4f13-0083-403d-97cb-3757a2483a16_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/09049289-4179-41be-8e96-32bbec4c194b_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/d0cfbfea-f757-47dd-ab87-0e1a87a41046_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97b40b87-01e8-496d-97da-23ad399276c3","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97b40b87-01e8-496d-97da-23ad399276c3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31558084","allele":{"id":"https://genegraph.clinicalgenome.org/r/db23244f-6ad1-493a-bd9f-ff83f5b51475","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000124.4(ERCC6):c.643G>T (p.Glu215Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10576142"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/39b21d84-a381-459c-93b5-e4363cbdd2e7","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39b21d84-a381-459c-93b5-e4363cbdd2e7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31558084","allele":{"id":"https://genegraph.clinicalgenome.org/r/aa0a3f61-3484-4628-b69c-1e4e67054770","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000124.4(ERCC6):c.1614_1616delinsAAACGTCTT (p.Thr539delinsAsnValPhe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320358"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d0cfbfea-f757-47dd-ab87-0e1a87a41046","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31558084","rdfs:label":"Zhang Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/aa0a3f61-3484-4628-b69c-1e4e67054770"},{"id":"https://genegraph.clinicalgenome.org/r/db23244f-6ad1-493a-bd9f-ff83f5b51475"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002213","obo:HP_0000708","obo:HP_0000670","obo:HP_0033725","obo:HP_0008887","obo:HP_0000964","obo:HP_0001249","obo:HP_0000529","obo:HP_0002119","obo:HP_0007064","obo:HP_0001272","obo:HP_0001268","obo:HP_0000490","obo:HP_0005328","obo:HP_0001730","obo:HP_0006482","obo:HP_0001263","obo:HP_0001510"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/39b21d84-a381-459c-93b5-e4363cbdd2e7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/97b40b87-01e8-496d-97da-23ad399276c3_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/81daffe7-420a-4405-97cc-9a7bdda7fac6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae33ce5f-3520-4903-9507-a42eb6210b91","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae33ce5f-3520-4903-9507-a42eb6210b91_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19894250","allele":{"id":"https://genegraph.clinicalgenome.org/r/2ac97265-caf6-475c-9b78-8f4f7cbe67c7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000124.4(ERCC6):c.2170-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1073323"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/75e19794-d67b-40ad-a025-31e17d7bef28","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/75e19794-d67b-40ad-a025-31e17d7bef28_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19894250","allele":{"id":"https://genegraph.clinicalgenome.org/r/9898bf6a-8f45-40bb-a147-2ef0d106085c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000124.4(ERCC6):c.2830-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA274705"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/81daffe7-420a-4405-97cc-9a7bdda7fac6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19894250","rdfs:label":"CS1GL","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":42,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/9898bf6a-8f45-40bb-a147-2ef0d106085c"},{"id":"https://genegraph.clinicalgenome.org/r/2ac97265-caf6-475c-9b78-8f4f7cbe67c7"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0004326","obo:HP_0000992","obo:HP_0000320","obo:HP_0000365","obo:HP_0011451","obo:HP_0001510","obo:HP_0001518","obo:HP_0000518","obo:HP_0010864","obo:HP_0000546"],"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ae33ce5f-3520-4903-9507-a42eb6210b91_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/75e19794-d67b-40ad-a025-31e17d7bef28_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/a5d00fc3-d524-4ccd-b78b-218c1bc8bb40_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5048a287-79a8-41a1-b227-4fa2171128f8","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5048a287-79a8-41a1-b227-4fa2171128f8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9443879","allele":{"id":"https://genegraph.clinicalgenome.org/r/0465350d-4916-4f6f-bf39-1dd0d49f90b3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000124.4(ERCC6):c.1357C>T (p.Arg453Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251920"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/579181f5-0966-465a-85fd-7cc93e62dcae","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/579181f5-0966-465a-85fd-7cc93e62dcae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9443879","allele":{"id":"https://genegraph.clinicalgenome.org/r/12f8189e-e32c-4813-9c87-58bdc25c9dbe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000124.4(ERCC6):c.2203C>T (p.Arg735Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115152"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a5d00fc3-d524-4ccd-b78b-218c1bc8bb40","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9443879","rdfs:label":"25627","allele":[{"id":"https://genegraph.clinicalgenome.org/r/12f8189e-e32c-4813-9c87-58bdc25c9dbe"},{"id":"https://genegraph.clinicalgenome.org/r/0465350d-4916-4f6f-bf39-1dd0d49f90b3"}],"detectionMethod":"Complementation group testing was performed and then sequencing. Variants were sequenced by means of the dideoxy termination procedure with T7 DNA polymerase and 35S-dATP, as described elsewhere (Steingrimsdottir et al. 1993).","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000580","obo:HP_0001288"],"secondTestingMethod":"Other","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5048a287-79a8-41a1-b227-4fa2171128f8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/579181f5-0966-465a-85fd-7cc93e62dcae_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/3dcac6eb-dded-49da-8f82-668f9f6cbf9c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d68f57ce-297a-4061-a6bd-caf0cc61cb6e","type":"EvidenceLine","dc:description":"Reduced by 1 full point (0.5 for both consanguinity and homozygosity) as to avoid over scoring.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d68f57ce-297a-4061-a6bd-caf0cc61cb6e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19894250","allele":{"id":"https://genegraph.clinicalgenome.org/r/e50232f9-76cf-4ea0-94d8-a5c730ab73a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000124.4(ERCC6):c.1954C>T (p.Arg652Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA274694"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3dcac6eb-dded-49da-8f82-668f9f6cbf9c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19894250","rdfs:label":"08STR4","ageType":"AgeAtReport","ageUnit":"Months","ageValue":30,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e50232f9-76cf-4ea0-94d8-a5c730ab73a2"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0011451","obo:HP_0000546","obo:HP_0000365","obo:HP_0006482","obo:HP_0004326","obo:HP_0000320","obo:HP_0000568","obo:HP_0010864","obo:HP_0000519","obo:HP_0001510"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d68f57ce-297a-4061-a6bd-caf0cc61cb6e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":5901,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/EeRJjAE8Hpw","type":"GeneValidityProposition","disease":"obo:MONDO_0100506","gene":"hgnc:3438","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e9dbf99e-d648-465c-8aa5-0840e76c0aeb-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}